Back to search

Article

Potency and efficacy of VP20-based vaccine against tilapia lake virus using different prime-boost vaccination regimens in tilapia

2022-06-01

Abstract excerpt

Tilapia lake virus (TiLV) is a newly emerged pathogen responsible for high mortality and economic losses in the global tilapia industry. Vaccination is the most effective way to prevent and control viral diseases. There is currently no vaccine on the market to control TiLV infections. Recently, we identified that TiLV segment 8 encoded a protein (VP20) with immunogenicity sufficient for use as a vaccine antigen. I...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2bc7af30-0c59-5450-8202-78e02118c4ce
DOI
10.1016/j.aquaculture.2021.736654
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Potency and efficacy of VP20-based vaccine against tilapia lake virus using different prime-boost vaccination regimens in tilapiaDOI 10.1016/j.aquaculture.2021.736654
Select a neighboring publication to make it the new centre.